Ferdinand W Janssen

6PUBLICATIONS
19CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 27, 2026
Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

|Apr 17, 2026
Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypes.

|Feb 19, 2026
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Milena Urbini, Thomas F Eleveld, Maurizio Polano

|Jan 08, 2025
Targeted Antibacterial Endolysin to Treat Infected Wounds on 3D Full-Thickness Skin Model: XZ.700 Efficacy.

Marisa Meloni, Bob de Rooij, Ferdinand W Janssen

|Sep 25, 2024
Author Correction: A comprehensive overview of liquid biopsy applications in pediatric solid tumors.

Ferdinand W Janssen, Nathalie S M Lak, Claudia Y Janda

|Aug 03, 2024
A comprehensive overview of liquid biopsy applications in pediatric solid tumors.

Ferdinand W Janssen, Nathalie S M Lak, Claudia Y Janda

Pageof 1

Frequent Collaborators

5 joint publications

Leendert H J Looijenga

3 joint publications

Thomas F Eleveld

2 joint publications

Michael T Meister

2 joint publications

Johannes H M Merks